Patient Population

Patients were treated with various regimens of TTX and/or placebo and were followed up to day 28. Patients enrolled had moderate to severe pain due to the chemotherapy, but were not on any chemotherapy during the trial. Various exams were done by the Investigator to verify they were in relatively good health and had no actively progressing disease at the time of enrolment.